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Abstract
In severe trauma and hemorrhage the early and empiric use of fresh frozen plasma (FFP) is
associated with decreased morbidity and mortality. However, utilization of FFP comes with
the significant burden of shipping and storage of frozen blood products. Dried or lyophilized
plasma (LP) can be stored at room temperature, transported easily, reconstituted rapidly
with ready availability in remote and austere environments. We have previously demon-
strated that FFP mitigates the endothelial injury that ensues after hemorrhagic shock (HS).
In the current study, we sought to determine whether LP has similar properties to FFP in its
ability to modulate endothelial dysfunction in vitro and in vivo. Single donor LP was com-
pared to single donor FFP using the following measures of endothelial cell (EC) function in
vitro: permeability and transendothelial monolayer resistance; adherens junction preserva-
tion; and leukocyte-EC adhesion. In vivo, using a model of murine HS, LP and FFP were
compared in measures of HS- induced pulmonary vascular inflammation and edema. Both
in vitro and in vivo in all measures of EC function, LP demonstrated similar effects to FFP.
Both FFP and LP similarly reduced EC permeability, increased transendothelial resistance,
decreased leukocyte-EC binding and persevered adherens junctions. In vivo, LP and FFP
both comparably reduced pulmonary injury, inflammation and vascular leak. Both FFP and
LP have similar potent protective effects on the vascular endothelium in vitro and in lung
function in vivo following hemorrhagic shock. These data support the further development of
LP as an effective plasma product for human use after trauma and hemorrhagic shock.
Introduction
Globally, it is estimated there are over 5 million deaths per year due to traumatic injury, many
of which occur from uncontrolled bleeding. [1] Hemorrhage in fact remains the number one
cause of early trauma deaths and the primary cause of potentially preventable deaths in both
military and civilian settings. In recent years, employing modern resuscitation strategies,
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which include the early, and empiric use of plasma in a balanced ratio with packed red cells
have reduced early mortality. [2–8] This decrease in mortality is thought to be more than just a
reduction in bleeding related deaths and is hypothesized to involve the protective effects of
plasma to an injured and impaired endothelium, termed the “endotheliopathy of trauma
(EoT).” [9,10] Clinically this is manifested as a pro-inflammatory state with vessel hyperperm-
ability and tissue edema, all of which can result in organ failures and late deaths.
While the use of plasma has demonstrated benefits on outcome, little is known about its
mechanism of action. Over the past few years pre-clinical and clinical studies have suggested
that the mechanism may not be solely related to hemostasis, but also due in part to its ability
to globally promote systemic vascular stability, defined by decreased endothelial cell (EC)
permeability, decreased inflammation in the lungs and systemically as well as improved hemo-
dynamic stabilization following hemorrhagic shock. [10–18] Plasma resuscitation in a hemor-
rhagic shock rodent model has also been shown to partially restore a damaged endothelial
glycocalyx, including syndecan-1, the structural backbone of the glycocalyx [14,17,19]. Resto-
ration of the glycocalyx may improve outcomes after trauma and hemorrhagic shock by atten-
uating leukocyte-EC adhesion, platelet adhesion, and inflammatory cytokine binding by
establishing a physical barrier between the blood and EC barrier. [19–25] Plasma and plasma
products have been shown to decrease endothelial cell permeability, inflammation, and lung
injury both in vitro and in vivo and may contribute to improved outcomes [10–18].
Despite its benefits, the use of fresh frozen plasma (FFP) in traumatic injury comes with a
significant logistical challenge and the burden of shipping and storage of frozen blood prod-
ucts around the world. Conversely, lyophilized plasma (LP) can be stored at room tempera-
ture, transported easily, and reconstituted rapidly in remote and austere environments. [26]
Due to its rapid reconstitution time, LP can be administered much earlier than FFP and is
ideal for pre-hospital use where transport times are lengthened due to location and logistical
challenges. Furthermore, the storage lesion that develops in thawed plasma would not occur
with LP, as only what is needed is reconstituted. Once thawed, fresh frozen plasma is approved
for use for up to five days when stored at 4˚C. Our group has shown that the beneficial effects
of FFP on EC function and hemodynamic stability in vitro and in vivo decrease over time from
day zero thru day five of storage. [27] Our collaborators have also shown that an increase in
TGF-β in day 5 FFP inhibits endothelial cell migration, which potentially results in diminished
repair of injured vessels and tissue during trauma and HS. [12] There is considerable interest
therefore to develop dried plasma products in the US that have expanded storage capabilities
and can be rapidly reconstituted. In addition, pathogen reduction is feasible for dried products
and can potentially reduce the risk of infection of new emerging pathogens and transfusion
transmitted infections [26]. We therefore sought to determine if lyophilized plasma would
demonstrate comparable protection to FFP by examining endothelial cell function in vitro and
lung function in vivo in a clinically relevant mouse model of hemorrhagic shock.
Materials and methods
Plasma
Fresh Frozen Plasma (FFP) type male O+ was obtained from Gulf Coast Regional Blood Cen-
ter and from Blood Center’s of the Pacific (BCP). Lyophilized type male O+ plasma was
obtained from the HEMOCON (Portland,OR) and reconstituted in buffer provided by Hem-
con (Portland, OR). The lyophilized plasma utilized in the current study tested was produced
as part of a contract from the US Army. The program made significant progress in optimizing
conditions, resulting in a process that yielded factor levels within the normal range, The prod-
uct proceeded to and was successful in a phase I clinical trial. [28] However, the company is no
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longer in business, but the same technology is currently being developed by Vascular Solutions
(Maple Grove, Minnesota) which is part of Teleflex (Wayne, PA). It is expected that this pro-
gram will produce a FDA approved product for US use by 2020–2021. [26]
In vitro studies
Primary cells and cell lines. Early passage Human Umbilical Vein Endothelial Cells
(HUVECS) were purchased from Lonza (Walkersville, MD). Cells were maintained in EGM-
2MV media (Lonza) and used for in-vitro VE-Cadherin and B-catenin staining and flow
cytometry. U937 cells were obtained from ATCC (Bethesda, MD) and passaged in RPMI with
10% fetal bovine serum. All experiments were conducted in U937 between passages 3–8. All
cell lines were maintained at 37˚C and 5% CO2 in a humidified incubator.
Resuscitation fluids. Treatment groups tested in vitro were 1) FFP (Day 0 freshly thawed)
2) LP 3) Lactated Ringers Solution (LR) and 4) no treatment (media alone). All fluids were
diluted to 10% or 30% into EC media- EGM-2MV. We have previously shown 10% dilution to
be effective. [12,16]
Endothelial cell (EC) permeability. Collagen-coated 0.4μm pore size inserts were ob-
tained from BD Biosciences. ECs were seeded at 40,000 cells per insert well in a total volume of
500μl of EGM-2 MV media and cultured for 8 hours to allow for cell attachment and adhesion.
When confluence was reached, monolayers of ECs in the transwells were pre-treated with the
five treatment groups (FFP, LP, LR and media control) for one hour at 10 and 30% total well
volume. Permeability was then induced in monolayers with 50ng/ml VEGF-A165 from R&D
(Minneapolis, MN), administered simultaneously with the addition of FITC-Dextran. EC
monolayer permeability was tested by adding 50μl of 2mg/mL 40 kDa dextran conjugated to
alexa fluor 480 (Sigma-Aldrich, St. Louis, MO) to the upper chamber of each well (final con-
centration). 75 μl samples were removed at timed intervals from the bottom well to determine
the amount of fluorescent signal that had passed through the monolayer, which directly corre-
lates to the degree of paracellular permeability in each sample. Measurements were determined
with a fluorimeter (Biotek Synergy Biotek Winooski, VT) using excitation and emission wave-
lengths of 485nm and 530nm, respectively, from samples obtained 45 minutes after addition of
FITC-Dextran. This is the same experiment that was run in Wataha et al. (2013) [16]
Endothelial Cell Impedance Assays (ECIS). Endothelial cell barrier function was
assessed as described in Potter et al. (2015) [18]. Briefly, trans-endothelial electrical resistance
(TEER) is measured by ECIS system (ECIS 1600, Applied BioPhysics, Troy, NY) Confluent
HUVECs were treated with 10% FFP, LP, LR or media alone and TEER measured at 4/16/64
kHz continuously for 2.5 hours afterward (n = 6 /group). Resistance measurements were
expressed as the area under the curve for 2 hours.
In vitro VE-cadherin and β-catenin staining. ECs at passage 3 were seeded into 8-well
glass chambered slides and grown for 48 hours at 37˚C. The cells were treated with 10% dilu-
tions of the groups diluted into EGM2-MV basal media for 1 hour, and then stimulated with
VEGF-A (50 ng/ml) for 30 minutes (R&D Systems #293-VE-010, Minneapolis, MN). The cells
were then fixed in 2% formaldehyde and blocked in TBS-T + 2.5% normal goat serum for 60
minutes at room temperature. A rabbit α-VE-cadherin antibody (1:400 dilution, Cell Signaling
#2500 Beverly, MA), and a mouse α-β-catenin antibody (1:200 dilution, Cell Signaling #2677)
were applied overnight at 4˚C and detected using an Alexa 488 α-rabbit antibody (1:500 dilu-
tion, Molecular Probes #A-11034, Invitrogen, Carlsbad, CA) and an Alexa 568 α-mouse anti-
body (1:500 dilution, Invitrogen Molecular Probes #A-11031, Invitrogen). The next day the
slides were mounted using ProLong Gold anti-fade reagent with DAPI (Molecular Probes P-
36931, Invitrogen) to obtain nuclear staining. Images of the cells were taken at 40x on a Nikon
LP attenuates vascular permeability, inflammation and lung injury in HS
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A1R confocal microscope (Nikon Instruments, Inc, Melville, NY). Merged images (yellow)
depict the degree of co-staining of VE-Cadherin and β-catenin indicating adherens junctions
(AJs) mobilized at the endothelial cell membranes.
Leukocyte binding assays. ECs were grown to confluence on 96-well plates. 104 cells/well
were seeded and incubated at 37˚C for two days or until confluent. Cells were pre-treated with
the treatment groups for 1 hour at 10 and 30% plasma product of total well volume. As we
have previously described, adhesion molecule expression was stimulated by the addition of
TNFα (50ng/ml) for 4 hours following pre-treatment of the cells. [16] U937 cells were fluores-
cently labeled with Calcein-AM (Invitrogen Carlsbad, CA). A total of 104 U937 cells, a well-
established monocyte line, were added to wells and allowed to adhere for one hour. Non-
adherent cells were gently washed away (3 washes) in PBS and labeled cells that remained
bound to the ECs were quantified by fluorescent readings on the Biotek Analyzer. This is the
same experiment that was run in Wataha et al. (2013) [16]
In vivo studies
Rodent model of hemorrhagic shock. All procedures performed were protocols
approved by the University of Texas Houston Medical School’s Institutional Animal Care and
Use Committee (IACUC). The experiments were conducted in compliance with the National
Institutes of Health guidelines on the use of laboratory animals. All animals were housed at
constant room temperature with a 12:12-h light-dark cycle with access to food and water ad
libitum. We used our established coagulopathic mouse model of trauma-hemorrhagic shock.
[15,18] Male C57BL/6J mice, 20–25 grams, underwent isoflurane anesthesia. A midline lapa-
rotomy incision was made, the organs and small bowel inspected, and then the incision closed.
Bilateral femoral arteries were cannulated for continuous hemodynamic monitoring and
blood withdrawal or resuscitation. Mice were bled to a mean arterial pressure (MAP) of 35±5
mmHg and maintained for 90 minutes. At the completion of the shock period, mice were
resuscitated with either LR at 3x shed blood volume or FFP or LP at 1x shed blood volume.
Mice will be awoken from anesthesia at the conclusion of resuscitation then underwent eutha-
nasia by CO2 inhalation confirmed by cervical dislocation at 3 hours as we have found this
time optimal to study organ function.[9]
Lung inflammation and histopathology. Lung inflammation was assessed by myeloper-
oxidase (MPO) immunostaining as in indicator of neutrophil influx. Paraffin-embedded tissue
was cut into 5 μm-thick sections then incubated with MPO primary antibody (1:100 MPO
mouse monoclonal antibody; Abcam, Cambridge, Mass) followed by incubation with second-
ary antibody (goat antiY-mouse; Alexa Fluor 568; Invitrogen). Two random images were
taken from each lung section with a fluorescent microscope (Nikon Eclipse Ti, Melville, NY)
at 200X magnification and immunofluorescence quantified using ImageJ software (National
Institutes of Health). Results are expressed as relative fluorescent units (RFU). Sectioned tissue
was also stained with hematoxylin and eosin (H&E) then scored by a blinded examiner for
alveolar thickness, capillary congestion, and cellularity as originally described by Hart et al.
and as we have employed. [14,29,30]
Lung vascular permeability. To measure Evans blue dye extravasation, animals received
an intravenous injection of 3% Evans blue (4 mL/kg) two hours after the completion of resus-
citation. One hour later, at the time of sacrifice, animals were perfused via right ventricle with
4˚C PBS for 10 minutes to remove intravascular dye followed by 4% paraformadehyde at 4˚C.
Lungs were harvested then incubated in N-methylformamide for 24 h at 55˚C to allow for dye
extraction. After centrifugation, absorbance was measured in the supernatant at 620 nm using
the VersaMax plate reader (Molecular Devices Inc, Sunnyvale, CA).
LP attenuates vascular permeability, inflammation and lung injury in HS
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Lung edema. Lung tissue was weighed and then dried to constant weight at 50˚C for 72
hours. The ratio of wet-to-dry was calculated by dividing the wet weight by the dry weight.
Statistical analysis. All data were analyzed by one-way analysis of variance (ANOVA)
with Tukey’s test for post-hoc analysis with p<0.05. Data are expressed as mean ± SEM. In
vitro data was repeated in triplicates unless indicated and for in vivo studies, n = at least 8/
group.
Results
FFP and LP decrease endothelial permeability in vitro
We have previously shown that FFP and pooled, solvent detergent treated spray dried plasma
decreased endothelial cell permeability in vitro. [16] In the current study, we sought to deter-
mine if LP had similar effects on endothelial permeability. Fig 1A and 1B demonstrate that
both LP and FFP attenuate EC permeability to FITC conjugated-dextran tracers over time
compared to LR and media alone at concentrations of 10% and 30% of the total fluid volume.
In support of these findings are the data shown in Fig 2 that EC monolayer resistance is simi-
larly increased by FFP and LP depicted as the raw traces in (Fig 2A) and the bar graph depic-
tions of total area under the curve (Fig 2A). Monolayer electrical resistance is directly
correlated to the permeability of an endothelial monolayer. [31,32] Increased resistance indi-
cates decreased permeability. These results both support the premise that FFP and LP equiva-
lently attenuate EC permeability and monolayer barrier dysfunction.
FFP and LP preserve EC adherens junctions on activated endothelial cells
To further understand at the molecular level the effects of LP and FFP on endothelial junctional
stability, we investigated the adherens junctions. Adherens junctions are critical regulators of
vascular endothelial junctional stability and composed of beta-catenin and VE-cadherin.
5 m
in
15
 m
in
30
 m
in
45
 m
in
60
 m
in
90
 m
in
12
0 m
in
0
500
1000
1500
2000
10% Permeability
Fl
uo
re
sc
en
ce
 in
te
ns
ity
Control
LR
FFP
LP
5 m
in
15
 m
in
30
 m
in
45
 m
in
60
 m
in
90
 m
in
12
0 m
in
0
5000
10000
15000
20000
30% Permeability
Fl
uo
re
sc
en
ce
 in
te
ns
ity
Control
LR
FFP
LP
A B
Fig 1. LP and FFP attenuate EC permeability on Transwells. Transwell permeability of treated wells to FITC-dextrans (40kD) after treatment with 10%(A) and 30%
(B) of the fluids tested respectively. FFP and LP are significantly less than control and LR at time points 30 minutes and beyond while FFP and LP are significantly
different on at the 90 and 120 time points, p< 0.05 via post hoc turkey tests of an unpaired Two-way ANOVA. Controls and FFP were featured in Wataha et al. (2013).
[16].
https://doi.org/10.1371/journal.pone.0192363.g001
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[20,33–36]. Monolayers stimulated with VEGF-A, an instigator of AJ breakdown and paracellu-
lar permeability, were stained for both beta-catenin and VE-Cadherin (Fig 3). FFP and LP both
qualitatively restored adherens junction integrity as depicted by enhanced staining pattern of
VE-Cadherin (green) and beta- catenin (red). Neither LR nor media alone had any notable
effects on preventing adherens junction breakdown by VEGF-A.
FFP and LP attenuate endothelial cell-leukocyte binding
We next sought to determine if plasma products modulated leukocyte binding to ECs. U937
cells, a monocyte cell line that we have used in the past on these studies of leukocyte-EC bind-
ing were utilized [16,33]. To stimulate U937 binding, ECs were treated with TNF-α then the
relative binding of calcein-labeled U937 cells bound to ECs was quantified by fluorimetry.
Binding studies revealed that treatment of the ECs with 30% and 10% LP significantly inhib-
ited U937 binding to the ECs (Fig 4A and 4B) compared to media alone and LR as depicted by
fold decrease in leukocyte binding. Only 30% FFP showed a significant inhibition of binding.
Furthermore, there were no significant differences found between the effects of FFP and LP on
leukocyte-EC adhesion at 10% but at 30% LP significantly decreased binding compared to
FFP.
LP reduces pulmonary vascular permeability, edema, and inflammation
following HS
To evaluate the ability of LP to reduce the HS-induced lung injury, we employed our estab-
lished murine model of fixed pressure HS and laparotomy (Fig 5). [16,17,34] [12,13,25] We
found that lung injury was significantly attenuated in LP and FFP treated mice as indicated by
histopathological analysis (Fig 6A–6E) of H&E stained sections and calculated lung injury
scores (Fig 6F). Myeloperoxidase (MPO) staining, an indication of neutrophil infiltration,
revealed decreased MPO staining in the lungs from LP and FFP treated mice compared to LR
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Fig 2. LP and FFP increase TEER of EC monolayers. (A) Mean average ECIS generated traces of the TEER of HUVECs treated with 10% media (control), LR, FFP or
LP. (B) Area under the curve analysis for thirty minutes after the addition of treatment.  = (p<0.05) compared to control via post hoc turkey tests of an unpaired one-
way ANOVA.
https://doi.org/10.1371/journal.pone.0192363.g002
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and shock alone and was comparable to shams. (Fig 7A). In a separate set of experiments, HS
mice treated with LP and FFP similarly decreased permeability and lung edema (Fig 7B and
7C). LP and FFP comparably decreased Evan’s Blue dye extravasation, indicative of permeabil-
ity and decreased lung wet:dry ratios compared to LR and shock alone.
Discussion
We have previously shown that fresh frozen plasma has potent protective effects on EC func-
tion and vascular barrier integrity in vitro and in vivo. [12,14,16,20] We now hypothesized that
the stabilizing effects of LP on the endothelium in vitro and in vivo would be superior to Lac-
tated Ringers solution and similar to our findings for FFP. We have indeed demonstrated that
LP and FFP similarly inhibited EC permeability and trans-endothelial monolayer resistances,
adherens junction reconstitution and leukocyte-EC binding in vitro. Minor differences
between the two were found in that in vitro, LP is more effective at inhibiting leukocyte adhe-
sion than FFP at the lower dose (10%). This is also the case for theability to inhibit permeability
to dextran dye in endothelial monolayers. These difference may be manifesting in vitro since
the donors of the LP are different than the FFP. However, these differences did not appear in
vivo as FFP and LP equivalently mitigated pulmonary vascular permeability and edema, lung
injury and inflammation induced by HS. Taken together, these studies support the central
premise that LP can potentially be used as a substitute to FFP to correct endothelial dysfunc-
tion and mitigate the endotheliopathy of trauma (EOT). [9]
FFP resuscitation has also been shown to partially restore the damaged endothelial glycoca-
lyx, and syndecan-1 expression. [13,15,20] Restoration of the glycocalyx physically reinforces
the endothelial barrier and attenuates leukocyte-endothelial cell adhesion. [21] We have not
examined the effect of LP on the glycocalyx but our current data suggests it would be equally
Fig 3. FFP and LP prevent VEGF disruption of adherens junctions. Cells were pretreated with LR, FFP, LP or not
treated for 1 hour before VEGF was added. Cells were fixed and stain for (A) Dapi (blue), β-Catenin (red) and
VE-Cadherin (green). In (B) it is qualitatively observed that FFP and LP preserve the overlap of VE-Cadherin and β-
Catenin (yellow) compare to untreated and LR controls.
https://doi.org/10.1371/journal.pone.0192363.g003
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Fig 4. LP and FFP reduce that amount of leukocyte binding in vitro. Fluorescently labeled U397 cells were added to wells of HUVEC
cells treated with 10(A) and 30(B) percent LR, FFP, LP or no treatment control. Unbound cells were removed after a period of one hour
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were featured in Wataha et al. (2013). [16].
https://doi.org/10.1371/journal.pone.0192363.g004
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restorative. Though we have focused our study on the lung, we have also shown that FFP mitigates
gut injury and inflammation in our mouse hemorrhagic shock model.[29] Additionally, work by
Alam and colleagues demonstrated that FFP decreased mortality, blood brain barrier compromise
and cerebral edema in a swine model of traumatic brain injury. [35] Based on the findings of the
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https://doi.org/10.1371/journal.pone.0192363.g005
Fig 6. LP and FFP reduce the damage done to the lungs by a model hemorrhagic shock. Representational images of lungs stained with H&E from Sham (A), Shock
(B), Shock+ LR (C), Shock + FFP (D) and Shock + LP (E). Histopathology scores average across all animals (F). Bars indicate significant differences (p< 0.05) via post
hoc tukey tests based on a one-way ANOVA. N.S. clarifies that the indicated groups are Not Significantly different.
https://doi.org/10.1371/journal.pone.0192363.g006
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current study, we anticipate that LP would also provide protection to HS and trauma induced gut
and brain compromise. This is a future direction of ongoing investigations.
The current study focused on the effects of LP on the endothelium not coagulation. Others
have demonstrated that LP has potent corrective effects on coagulopathy in pre-clinical trauma
bleeding models, similar to FFP. Lyophilized or freeze dried plasma has also been shown to
have similar beneficial effects in reducing inflammation and mortality after HS in large animal
models. [35,37–40]
There are limitations of the current study. Both the FFP and LP were from single donors
but as we have demonstrated, donor variability can be present within single donor units of
plasma. [23] Another limitation of the study is the use of human plasma in mice. Using human
plasma in mice affords us the opportunity to study the clinical product used in humans in pre-
clinical models of hemorrhagic shock. We believe this to be of important translational benefit
but xeno-incompatibility is a possible confounder. However, when we compared the use of
mouse to human plasma in our murine model of HS we found a lack of specifies specific differ-
ences in pulmonary indices of injury, permeability or edema despite some differences in
hemodynamic parameters. [41] While our model of trauma/hemorrhagic shock does result in
coagulopathy as shown in our manuscript below by Peng et al. We did not access coagulation
in the current study, we were focused on endothelial function and inflammation. However, in
a study by Lee et al, full volume reconstituted LP retained on average 86% coagulation factor
activity compared to fresh plasma and when used in 1:1 ratios with red blood cells demon-
strated superior hemostatic efficacy compared to FFP.
In summary, our data support the concept that lyophilized plasma has potent systemic effects
on the vascular endothelium and post-hemorrhagic shock lung and mitigates the endotheliopa-
thy of trauma (EOT). Since there is a dire clinical need for dried plasma products in remote and
austere settings, both in the military and civilian settings, these data support the premise that LP
can be used in lieu of FFP in bleeding patients following severe traumatic injury.
Supporting information
S1 File. Data file for all figures. This file contains the raw data for all graphs contained in this
manuscript.
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